Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is ... inhaled corticosteroid medication for a short period.

A Minnesota mom will spend less than four years in prison after pleading guilty to manslaughter after she and her husband ...

The main patent on Advair (fluticasone+salmeterol ... Wixela Inhub is indicated for the twice daily treatment of asthma in patients age four and older not adequately controlled on long-term ...

A mom in Minnesota is heading to prison for causing the death of her daughter after she refused to let the parents of one of ...

GSK’s new asthma ... Advair/Seretide, but won’t come close to replacing the older drug’s $5 billion in annual sales. Relvar Ellipta is a once-daily dual combination treatment comprising ...

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

Adults with attention-deficit/hyperactivity disorder (ADHD) who use an extended-release medication are more likely to ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

Beyond Cancer: Confronting the Challenges of Survivorship In this series, experts from Duke Cancer Institute discuss how the integration of cancer treatment and primary care is improving patient ...